Every story in this issue with a short summary, so you can decide what to read before leaving the site. Summaries are written by AI (Claude) only from each publisher's own description and checked by Jev for anything not in that description. They are not full translations. Follow "Read the original" for the full story.
Korean medical AI company Lunit is seeking to embed its cancer pathology software into pharmaceutical research workflows through a partnership with U.S.-based Discovery Life Sciences. Discovery Life Sciences is a laboratory services provider supporting hundreds of clinical trials.
Read the original →A multimodal deep learning model combining MRI scans with clinical data classifies Alzheimer's disease stages with up to 95 percent accuracy. The approach offers a promising path toward earlier diagnosis.
Read the original →Researchers developed EpiScreen, an AI system that distinguished epilepsy from psychogenic non-epileptic seizures using clinical notes from 13,633 patient records across two institutions. AI assistance improved neurologists’ classification accuracy in a retrospective assessment of 300 cases. Prospective studies must establish its performance and benefits in routine clinical care.
Read the original →Mount Sinai researchers tested 20 AI models. They found that a safety prompt cut harmful clinical choices from 16.6% to 10.1%.
Read the original →A new risk-calibrated tabular Transformer achieves state-of-the-art Alzheimer's disease staging. It calibrates its confidence and abstains on uncertain cases.
Read the original →A model can perform well and still fail in practice if alerts arrive at the wrong time, staff cannot act on them, or the fallback collapses.
Read the original →AI is helping foresters at Valmiki Tiger Reserve tackle human-wildlife conflict by providing early warnings of animal movement and human presence along vulnerable forest boundaries. Smart cameras were installed on the eastern periphery of Division I between May and Aug. They help field teams monitor wildlife activity and identify potential conflict zones.
Read the original →Taiwan’s healthcare technology sector has no shortage of devices, AI models or clinical data. The harder question is whether these technologies can validate across different patient populations, clear U.S. regulatory requirements, fit American clinical workflows and find partners able to deploy and service them locally.
Read the original →Five police forces decided not to continue using software from a US tech firm after a two-year trial.
Read the original →An agreement between the A.I. duPont Charitable Trust, Nemours Foundation and Delaware DOJ will advance childhood health in Delaware.
Read the original →AI adoption in clinical trials faces validation and governance gaps, not technical doubts. Organizations need process infrastructure and proper sequencing.
Read the original →Chew cautioned that AI's growing capabilities would require stronger safeguards, particularly as autonomous systems become more widely adopted.
Read the original →A quantitative analysis of 42 medical AI policies from seven major economies finds strong strategic vision but weak implementation tools. Only two policies earned a top-grade rating.
Read the original →Hangzhou Diagens Biotechnology's stock is down about 37.3% over the past month. Recent discussion took place at the 2026 Festival of Medical AI.
Read the original →A Lancet commission ranks 17 major threats to health through 2100. It finds that nuclear war and malicious AI carry a real risk of human extinction.
Read the original →On Friday, October 9, 2026, all three major US stock indexes closed at highs. The S&P 500 rose 0.59% to 7,811.54, the Nasdaq Composite rose 0.64% to 27,366.17, and the Dow Jones Industrial Average rose 0.83% to 51,654.95. ARK's trading increased exposure to autonomous systems, warehouse robots, gene editing and precision diagnostics.
Read the original →The Re▶︎CAMPUS organizing committee announced the second edition of the event in a press release dated October 12, 2026. It will take place on Tuesday, November 3, 2026 (a national holiday) at BPM in Ikejiri-Ohashi. The event is described as an adult cultural festival for about 300 people combining food, experiences and networking.
Read the original →